Ovid Therapeutics share price logo

Ovid Therapeutics

NASDAQ: OVID

Small Cap

$2.69

-0.01

(-0.37%)

as on

Ovid Therapeutics Stock Performance

as on September 19, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $2.63
    $2.73
    downward going graph

    2.23%

    Downside

    1.49%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.12
    $3.11
    downward going graph

    58.36%

    Downside

    15.43%

    Upside

    downward going graph

Ovid Therapeutics share price movements today

Previous Close
$2.70
Open
$2.68
Volume
1.3M
Market Cap
$523.4M
Day's Low - High
$2.63 - $2.73
52 Week Low - High
$1.12 - $3.11

Ovid Therapeutics Historical Returns

1 Month Return
-7.85 %
3 Month Return
+ 18.94 %
1 Year Return
+ 123.14 %
3 Year Return
-29.87 %
5 Year Return
-19.88 %

Ovid Therapeutics Stock Fundamentals & Key Indicators

Check Ovid Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$523.4M

EPS (TTM)

-0.48

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-5.62

Industry PE ratio

-6.87

PEG Ratio

0.15911380382224277

EBITDA

-35.7M

Revenue (TTM)

1.6M

Profit Margin

100.00%

Return On Equity TTM

-23.64%

Ovid Therapeutics Stock Valuation

Track how Ovid Therapeutics P/E has moved over time to understand its valuation trends.

Ovid Therapeutics in the last 5 years

  • Overview

  • Trends

Lowest (-6.79x)

December 31, 2025

Industry (-6.87x)

December 31, 2025

Today (-6.79x)

December 31, 2025

Highest (1.76x)

December 31, 2021

LowHigh

Today’s Price to Earnings Ratio: -6.79x

Ovid Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Ovid Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$523.4M-19.88%-5.62100.00%0.00%
BUY$63.1B-63.24%-19.81-12.57%0.00%
BUY$130.1B174.21%29.8186.04%0.00%
BUY$79.7B21.1%18.4884.86%0.48%

Stock Returns calculator for Ovid Therapeutics Stock including INR - Dollar returns

The Ovid Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Ovid Therapeutics investment value today

Current value as on today

₹2,41,390

Returns

₹1,41,390

(+141.39%)

Returns from Ovid Therapeutics Stock

₹1,22,314 (+122.31%)

Dollar Impact

₹19,076 (+19.08%)

Analyst Recommendation on Ovid Therapeutics Stock

Based on 7 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 7 analysts, 100% of analysts recommend a 'BUY' rating for Ovid Therapeutics. Average target price of $5.92

Ovid Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Ovid Therapeutics.

What analysts predicted

54.56%UPSIDE

Target Price

$5.92

Current Price

$2.69

Analyzed by

7 Analysts

Target

$5.92

Ovid Therapeutics target price $5.92, a slight upside of 54.56% compared to current price of $2.69. According to 7 analysts rating.

Indian Investors' Interest in Ovid Therapeutics Stock

Search interest for Ovid Therapeutics Stock has decreased by -31% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-31% versus previous 30 day period

Ovid Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
0
0
0
0
0
6
0
0
-
0
Gross Profit
0
0
0
0
0
6
0
0
-
0
Operating Income
-17
-20
-13
-10
-12
-5
-12
-12
-17
-15
EBITDA
-11
8
-13
-10
-10
-4
-12
9
-17
-15
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-11
8
-14
-9
-10
-4
-12
9
-16
-15
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-11
8
-14
-9
-10
-4
-12
9
-16
-15
Net Profit Margin
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
0.00%
100.00%

Ovid Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
12
208
1
0
0
7
Gross Profit
0
0
-
12
208
1
0
0
6
Operating Income
-65
-52
-61
-81
124
-55
-59
-61
-42
EBITDA
-64
-52
-61
-81
124
-54
-57
-57
-17
Interest Expense
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
1
0
0
0
Income Before Tax
-64
-51
-60
-81
124
-54
-52
-26
-17
Income Tax Expense
0
-
-
-
1
-
-
-
-
Net Income
-64
-51
-60
-81
122
-54
-52
-26
-17
Net Profit Margin
0.00%
0.00%
0.00%
100.00%
100.00%
100.00%
100.00%
100.00%
95.86%

Ovid Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-11
8
-14
-9
-10
-4
-12
9
-16
-15
Operating Cash Flow
-16
-14
-15
-10
-10
-4
-12
-10
-13
-17
Investing Cash Flow
20
12
0
21
5
12
5
-72
5
-86
Financing Cash Flow
0
0
0
-
0
-
0
75
88
21
Change in Cash
3
-1
-14
11
-5
7
-7
-7
80
-82

Ovid Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-64
-51
-60
-81
122
-54
-52
-26
-17
Operating Cash Flow
-31
-45
-51
-51
118
-55
-45
-55
-38
Investing Cash Flow
0
-5
-30
34
-1
-87
-2
54
-49
Financing Cash Flow
66
0
86
47
0
0
30
0
75
Change in Cash
35
-50
5
30
117
-142
-17
0
-13

Mutual Funds that own Ovid Therapeutics Stock

Check out the Mutual Funds with significant holdings in Ovid Therapeutics.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
2.641717%
5159218
Federated Hermes Equity Funds
2.133237%
4166166
MUTUAL FUND SERIES TRUST
1.482654%
2895593
Fidelity Concord Street Trust
0.280194%
547214
Bridgeway Funds, Inc.
0.069586%
135900

Global Institutional Holdings in Ovid Therapeutics

Funds
Holdings
Peter Kolchinsky
5.38%
Vanguard
4.66%
iShares
3.25%
SPDR
2.85%
Richard Driehaus
0.72%

Insights on Ovid Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 132.0K → 733.0K (in $), with an average increase of 41.8% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -16.98M → -15.00M (in $), with an average increase of 13.2% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, OVID stock has moved up by 122.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 48.8% return, outperforming this stock by 80.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 510.3% return, outperforming this stock by 388.0%

About Ovid Therapeutics

Ovid Therapeutics Inc. is a biopharmaceutical firm dedicated to creating significant treatments for individuals and families impacted by neurological disorders across the United States. The company's robust pipeline features several key therapeutic candidates: OV101, a drug candidate currently undergoing Phase 2A clinical trials for Fragile X syndrome; OV329, an inhibitor targeting GABA aminotransferase, aimed at managing seizures linked to tuberous sclerosis complex and infantile spasms; and OV350, a small molecule developed to address various forms of epilepsy. Beyond these, Ovid is also advancing OV882, a short hairpin RNA (shRNA) gene therapy designed to treat Angelman syndrome, and OV815, targeting neurological disorders connected to the kinesin-family of proteins. To bolster its research and development efforts, Ovid maintains licensing and collaborative agreements with prominent entities such as Healx, AstraZeneca AB, H. Lundbeck A/S, Northwestern University, and Marinus Pharmaceuticals, Inc. Established in 2014, the company's corporate headquarters are situated in New York, New York.
OrganisationOvid Therapeutics
HeadquartersHudson Commons, New York City, NY, 10001, US
IndustryBiotechnology
CEOMargaret Alexander
E-voting on sharesClick here to vote

Key Management of Ovid Therapeutics

Name

Title

Dr. Julia Tsai Ph.D.

Senior Vice President of Clinical Development

Ms. Victoria Fort

Chief Strategy Officer

Dr. Petra Kaufmann M.D., M.S.

Chief Medical Officer

Dr. Jeremy Max Levin Ba Zoology, Dphil, M.D., Mb Bchir, Ph.D.

Co-Founder & Executive Chairman

Mr. Charles Ross Carter M.B.A., M.S.

CFO, Principal Financial Officer, Principal Accounting Officer & Secretary

Dr. Zhong Zhong Ph.D.

Chief Scientific Officer

Dr. Manal Morsy M.B.A., M.D., PH.D.

Chief Regulatory Officer

Ms. Margaret Alexander

CEO, President & Director

Mr. Jeffrey A. Rona

Advisor

Dr. Toshiya Nishi D.V.M.

Head of Epilepsy Research

FAQs

What is Ovid Therapeutics share price today?

Ovid Therapeutics share price today is $2.69 as on at the close of the market. Ovid Therapeutics share today touched a day high of $2.73 and a low of $2.63.

What is the 52 week high and 52 week low for Ovid Therapeutics share?

Ovid Therapeutics share touched a 52 week high of $3.11 on and a 52 week low of $1.12 on . Ovid Therapeutics stock price today i.e. is closed at $2.69,which is 13.37% down from its 52 week high and 140.18% up from its 52 week low.

What is Ovid Therapeutics's market capitalisation today?

Ovid Therapeutics market capitalisation is $0.00T as on .

How to invest in Ovid Therapeutics Stock (OVID) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Ovid Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Ovid Therapeutics Shares that will get you 0.5576 shares as per Ovid Therapeutics share price of $2.69 per share as on September 19, 2026 at 8:46 am IST.

What is the minimum amount required to buy Ovid Therapeutics Stock (OVID) from India?

Indian investors can start investing in Ovid Therapeutics (OVID) shares with as little as ₹95.88 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.80 in Ovid Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Ovid Therapeutics share’s latest price of $2.69 as on September 19, 2026 at 8:46 am IST, you will get 3.7175 shares of Ovid Therapeutics. Learn more about fractional shares .

What are the returns that Ovid Therapeutics has given to Indian investors in the last 5 years?

Ovid Therapeutics stock has given -19.88% share price returns and 30.25% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?